CIK 0001005286
- Accelerated filer
- Smaller reporting company
LIFECORE BIOMEDICAL, INC. \DE\
Sign in to watch- Ticker
- LFCR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- May 25
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943025618
- Phone
- +1 952-368-4300
- Business address
- 3515 LYMAN BOULEVARD, CHASKA, MN, 55318
- Former names
- LANDEC CORP \CA\
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-25 | Hall James G Executive Vice President | Shares withheld for taxes | −1,511 | $9.42 | $14K | 11,757 |
| 2019-05-25 | Hall James G Executive Vice President | Exercise or conversion · Restricted Stock Unit | −5,000 | 0 | ||
| 2019-05-25 | Javid Parker K Vice President | Exercise or conversion | +10,000 | $9.42 | $94K | 10,000 |
| 2019-05-25 | Javid Parker K Vice President | Shares withheld for taxes | −3,528 | $9.42 | $33K | 6,472 |
| 2019-05-25 | Javid Parker K Vice President | Exercise or conversion · Restricted Stock Unit | −10,000 | 0 | ||
| 2019-05-24 | PANKOPF TONIA L Director | Exercise or conversion | +3,334 | $9.01 | $30K | 28,464 |
| 2019-05-24 | PANKOPF TONIA L Director | Exercise or conversion · Nonstatutory Stock Option (Right to Buy) | +3,334 | 3,333 | ||
| 2019-05-23 | Hemmeter Molly Chief Executive Officer | Exercise or conversion | +71,575 | $9.35 | $669K | 179,765 |
| 2019-05-23 | Hemmeter Molly Chief Executive Officer | Shares withheld for taxes | −24,750 | $9.35 | $231K | 155,015 |
| 2019-05-23 | Hemmeter Molly Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −71,575 | $9.35 | $669K | 71,575 |
| 2019-05-23 | GOLDBY STEVEN D Director | Exercise or conversion | +4,240 | $9.35 | $40K | 73,137 |
| 2019-05-23 | GOLDBY STEVEN D Director | Exercise or conversion · Restricted Stock Unit | −4,240 | 0 | ||
| 2019-05-23 | Hemmeter Molly Chief Executive Officer | Exercise or conversion | +71,575 | $9.35 | $669K | 204,975 |
| 2019-05-23 | Hemmeter Molly Chief Executive Officer | Shares withheld for taxes | −24,750 | $9.35 | $231K | 180,225 |
| 2019-05-23 | Hemmeter Molly Chief Executive Officer | Exercise or conversion · Restricted Stock Unit | −71,575 | $9.35 | $669K | 71,575 |
| 2019-05-23 | Bolles Albert D. CEO | Grant or award · Right to Buy Restricted Stock Units (RSU) | +55,000 | 55,000 | ||
| 2019-05-23 | Bolles Albert D. CEO | Grant or award · Non-Qualified Stock Option (Right to Buy) | +129,915 | $9.35 | $1.2M | 129,915 |
| 2019-05-23 | Bolles Albert D. CEO | Grant or award · Incentive Stock Option (Right to Buy) | +32,085 | $9.35 | $300K | 162,000 |
| 2019-05-23 | Hemmeter Molly Chief Executive Officer | Exercise or conversion | +71,574 | $9.35 | $669K | 204,974 |
| 2019-05-23 | Hemmeter Molly Chief Executive Officer | Shares withheld for taxes | −24,815 | $9.35 | $232K | 180,159 |
Page 21 of 27 · 528 trades